D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.32% |
| 2 | Healthcare | 8.96% |
| 3 | Financials | 7.81% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Arcosa
ACA
$7.14B
| $1.62M | ﹤0.01% |
29,904
-43,230
| -59% | -$2.57M |
|
2952
Amphastar Pharmaceuticals
AMPH
$892M
| $1.62M | ﹤0.01% |
57,948
+69
| +0.1% | +$2K |
|
2953
Lithia Motors
LAD
$8.1B
| $1.62M | ﹤0.01% |
7,921
-11,455
| -59% | -$2.45M |
|
|
HSKA
2954
DELISTED
Heska Corp
HSKA
| $1.62M | ﹤0.01% |
26,052
+17,008
| +188% | +$1.15M |
|
2955
PUT
Invesco
IVZ
$14.1B
| $1.62M | ﹤0.01% |
90,000
-60,400
| -40% | -$1.03M |
|
2956
Clearwater Paper
CLW
$367M
| $1.62M | ﹤0.01% |
42,807
-21,750
| -34% | -$848K |
|
|
ENER
2957
DELISTED
Accretion Acquisition Corp
ENER
| $1.62M | ﹤0.01% |
160,525
| – | – |
|
2958
Prothena Corp
PRTA
$444M
| $1.62M | ﹤0.01% |
26,856
-78,374
| -74% | -$4.59M |
|
|
TARO
2959
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.62M | ﹤0.01% |
55,652
+403
| +0.7% | +$12K |
|
2960
CALL
Amkor Technology
AMKR
$13.4B
| $1.61M | ﹤0.01% |
+67,300
| New | +$1.56M |
|
2961
Brookfield Renewable
BEPC
$6.18B
| $1.61M | ﹤0.01% |
58,568
+37,203
| +174% | +$1.15M |
|
2962
First Internet Bancorp
INBK
$256M
| $1.61M | ﹤0.01% |
66,423
+15,436
| +30% | +$408K |
|
2963
PUT
WD-40
WDFC
$3.15B
| $1.61M | ﹤0.01% |
10,000
| – | – |
|
2964
Dorman Products
DORM
$4.23B
| $1.61M | ﹤0.01% |
19,896
-10,940
| -35% | -$929K |
|
|
EGRX
2965
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.61M | ﹤0.01% |
54,917
+1,023
| +2% | +$32.5K |
|
2966
Bumble
BMBL
$397M
| $1.6M | ﹤0.01% |
76,215
-221,954
| -74% | -$5.11M |
|
2967
Harrow
HROW
$1.47B
| $1.6M | ﹤0.01% |
+108,526
| New | +$1.3M |
|
2968
Adecoagro
AGRO
$1.34B
| $1.6M | ﹤0.01% |
192,534
-341,250
| -64% | -$2.79M |
|
|
PTVE
2969
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.59M | ﹤0.01% |
140,389
-21,407
| -13% | -$234K |
|
|
SKYT
2970
DELISTED
SkyWater Technology
SKYT
| $1.59M | ﹤0.01% |
223,499
+130,015
| +139% | +$1.1M |
|
2971
Simmons First National
SFNC
$3.47B
| $1.59M | ﹤0.01% |
73,467
-94,432
| -56% | -$2.14M |
|
|
OLK
2972
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $1.58M | ﹤0.01% |
62,444
+12,197
| +24% | +$245K |
|
|
EWCZ
2973
DELISTED
European Wax Center
EWCZ
| $1.58M | ﹤0.01% |
127,262
+80,479
| +172% | +$1.16M |
|
2974
MiMedx Group
MDXG
$606M
| $1.58M | ﹤0.01% |
568,226
+101,289
| +22% | +$303K |
|
|
RPTX
2975
DELISTED
Repare Therapeutics
RPTX
| $1.58M | ﹤0.01% |
107,274
+41,890
| +64% | +$627K |
|
Similar funds
D.E. Shaw & Co's Q4 2022 Portfolio in Review
As of Q4 2022, D.E. Shaw & Co held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
D.E. Shaw & Co's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- D.E. Shaw & Co's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- D.E. Shaw & Co added most to Tesla in Q4 2022, an estimated $826M increase.
- D.E. Shaw & Co's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- D.E. Shaw & Co fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- D.E. Shaw & Co's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- D.E. Shaw & Co opened 475 new positions and closed 783 in Q4 2022.
- D.E. Shaw & Co's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.